slides · global inventory
All filtered slides
Global slide inventory for the active corpus filters, with each row opening the slide detail view.
Corpus coverage
319,975 slides
319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.
- Total slides
- 319,975
- Described
- 319,974
- Pending
- 1
100%ready for canon
Slide type composition
dynamicclickable
Slide type
Showing 319,974 described slides — 100.0% of 319,975 rendered pages
+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs
Tile area is proportional to slide count. Click a category to open its subtype map.
all document kinds · all orientations
Slide collection
226,951-226,980 of 319,975
23
Includes a clinical pipeline chart and a list of recent cell therapy acquisitions/partnerships.AstraZeneca | Results Presentation Deck | 45 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
24
Includes a 25-year anniversary graphic and a headshot of the CEO.AstraZeneca | Results Presentation Deck | 45 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
25
Slide 25 of a conference presentation deck.AstraZeneca | Results Presentation Deck | 45 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
26
The slide uses a comparison layout to contrast two distinct drug development programs.AstraZeneca | Results Presentation Deck | 45 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
27
The slide serves as a transition or conclusion to the presentation.AstraZeneca | Results Presentation Deck | 45 slides · AstraZeneca
Conference presentation Investor relations Beat · ActionLoop · Why Now1 hit
28
The slide uses a two-column layout to distinguish between near-term Phase III catalysts and early-stage pipeline confidence builders.AstraZeneca | Results Presentation Deck | 45 slides · AstraZeneca
Conference presentation Investor relations Beat · ActionLoop · Why Now1 hit
29
The slide serves as a transition or cover page for the CEO Closing Remarks section.AstraZeneca | Results Presentation Deck | 45 slides · AstraZeneca
Conference presentation Investor relations Beat · ActionLoop · Why Now1 hit
30
The slide features a grid of headshots with names and titles.AstraZeneca | Results Presentation Deck | 45 slides · AstraZeneca
Conference presentation Investor relations Beat · ActionLoop · Why Now1 hit
31
AstraZeneca | Results Presentation Deck | 45 slidesAstraZeneca | Results Presentation Deck | 45 slides · AstraZeneca
Conference presentation Investor relations 1 hit
32
AstraZeneca | Results Presentation Deck | 45 slidesAstraZeneca | Results Presentation Deck | 45 slides · AstraZeneca
Conference presentation Investor relations 1 hit
33
AstraZeneca | Results Presentation Deck | 45 slidesAstraZeneca | Results Presentation Deck | 45 slides · AstraZeneca
Conference presentation Investor relations 1 hit
34
The slide highlights progress against specific environmental targets and participation in global sustainability forums.AstraZeneca | Results Presentation Deck | 45 slides · AstraZeneca
Conference presentation Investor relations 1 hit
35
The slide uses a grid layout to categorize clinical trials by disease stage and molecular profile, highlighting established standards of care.AstraZeneca | Results Presentation Deck | 45 slides · AstraZeneca
Conference presentation Investor relations 1 hit
36
The slide uses a matrix structure to map clinical trials (e.g., DESTINY-Breast, TROPION-Breast) against patient segments (HER2+, HR+, TNBC, gBRCAm) and treatment stages (Early vs Metastatic).AstraZeneca | Results Presentation Deck | 45 slides · AstraZeneca
Conference presentation Investor relations 1 hit
37
The slide uses a custom matrix-style layout to map clinical trials and therapeutic strategies against patient segments.AstraZeneca | Results Presentation Deck | 45 slides · AstraZeneca
Conference presentation Investor relations 1 hit
38
The chart tracks revenue performance across three segments over nine quarters.AstraZeneca | Results Presentation Deck | 45 slides · AstraZeneca
Conference presentation Investor relations 1 hit
39
Data presented in stacked bar charts with corresponding data tables below each chart.AstraZeneca | Results Presentation Deck | 45 slides · AstraZeneca
Conference presentation Investor relations 1 hit
40
The slide contains two stacked bar charts with corresponding data tables below them.AstraZeneca | Results Presentation Deck | 45 slides · AstraZeneca
Conference presentation Investor relations 1 hit
41
The slide displays two stacked bar charts with corresponding data tables underneath each.AstraZeneca | Results Presentation Deck | 45 slides · AstraZeneca
Conference presentation Investor relations 1 hit
42
Data presented as stacked bar charts with corresponding data tables below each chart.AstraZeneca | Results Presentation Deck | 45 slides · AstraZeneca
Conference presentation Investor relations 1 hit
43
Data presented in stacked bar charts with corresponding data tables below each chart.AstraZeneca | Results Presentation Deck | 45 slides · AstraZeneca
Conference presentation Investor relations 1 hit
44
Data presented in stacked bar charts with corresponding data tables below each chart.AstraZeneca | Results Presentation Deck | 45 slides · AstraZeneca
Conference presentation Investor relations 1 hit
45
Data presented in stacked bar charts with corresponding data tables below each chart.AstraZeneca | Results Presentation Deck | 45 slides · AstraZeneca
Conference presentation Investor relations 1 hit
01
Azek | Results Presentation Deck | 21 slidesAzek | Results Presentation Deck | 21 slides · Azek
Conference presentation Investor relations 1 hit
02
Azek | Results Presentation Deck | 21 slidesAzek | Results Presentation Deck | 21 slides · Azek
Conference presentation Investor relations 1 hit
03
The slide uses a split-layout design with a dark blue sidebar for product lists and a large hero image of a house exterior on the right.Azek | Results Presentation Deck | 21 slides · Azek
Conference presentation Investor relations 1 hit
04
The slide uses a temple metaphor to illustrate strategic pillars.Azek | Results Presentation Deck | 21 slides · Azek
Conference presentation Investor relations 1 hit
05
Includes CAGR metrics and Adjusted EBITDA margin percentages.Azek | Results Presentation Deck | 21 slides · Azek
Conference presentation Investor relations 1 hit
06
Includes specific financial metrics like 23.2% margin and $100M share repurchase.Azek | Results Presentation Deck | 21 slides · Azek
Conference presentation Investor relations 1 hit
07
Includes specific y/y growth percentages and margin expansion data.Azek | Results Presentation Deck | 21 slides · Azek
Conference presentation Investor relations 1 hit